AlphaCrest Capital Management LLC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 179 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
AlphaCrest Capital Management LLC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$698,000
+39.9%
53,151
+2.9%
0.06%
+7.4%
Q3 2020$499,000
+136.5%
51,630
+180.3%
0.05%
+54.3%
Q2 2020$211,000
-43.7%
18,418
-49.1%
0.04%
-22.2%
Q1 2020$375,000
-0.3%
36,218
+58.1%
0.04%
+45.2%
Q4 2019$376,000
-45.4%
22,911
-55.9%
0.03%
-26.2%
Q3 2019$689,000
+44.4%
51,900
+100.4%
0.04%
-41.7%
Q1 2019$477,00025,9000.07%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Profit Investment Management, LLC 326,997$1,412,6271.00%
Stonepine Capital Management, LLC 477,903$2,064,5410.69%
Krensavage Asset Management, LLC 360,429$1,5570.57%
Nantahala Capital Management 1,000,000$4,320,0000.37%
Monaco Asset Management SAM 135,000$583,2000.17%
CTC Alternative Strategies, Ltd. 18,400$79,4880.15%
GSA CAPITAL PARTNERS LLP 406,019$1,7540.15%
Sio Capital Management, LLC 97,616$421,7010.13%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$673,9200.13%
Virtus ETF Advisers LLC 48,530$209,6500.13%
View complete list of VANDA PHARMACEUTICALS INC shareholders